FIELD: biotechnologies.
SUBSTANCE: invention describes a composition for induction of immune response against P. gingivalis, which contains an effective amount of one of the above chimeric or hybrid proteins, a prophylaxis method of a state or a disease related to P. Gingivalis, and a method for reduction of incidence or severity of the state or disease related to P. gingivalis with their application. Besides, the invention describes use of the above chimeric or hybrid proteins for determination of antibodies to P. Gingivalis in a biological specimen.
EFFECT: invention allows effective induction of immune response against the specified etiologic agent.
16 cl, 7 dwg, 4 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OR PREVENTION OF INFECTION | 2011 |
|
RU2617399C2 |
| ANTIBODY AGAINST LAG-3, ITS ANTIGEN-BINDING FRAGMENT AND THEIR PHARMACEUTICAL APPLICATION | 2017 |
|
RU2757813C2 |
| AGENTS AND METHODS BASED ON USING FIBRONECTIN OF DOMAIN EDA | 2006 |
|
RU2430738C2 |
| ANTIBODIES AGAINST HUMAN GDF8 | 2011 |
|
RU2567805C2 |
| PHARMACEUTICAL COMPOSITION FOR LIVER CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2640245C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF GALLBLADDER CANCER | 2013 |
|
RU2649802C2 |
| MUTANT POLYMERASES OF HEPATITIS B VIRUS | 2012 |
|
RU2625021C2 |
| HYBRID POLYPEPTIDE, PRESENTING AMINO ACID SEQUENCES, AND ITS APPLICATION | 2012 |
|
RU2630660C2 |
| RECOMBINANT ADEN-ASSOCIATED VIRUS, WHICH IS HYBRID OF AAV9 AND AAVrh74 SEROTYPES, WITH REDUCED TROPISM FOR LIVER TISSUE | 2019 |
|
RU2812279C2 |
| AGONIST NOTCH3 ANTIBODIES AND APPLICATION THEREOF FOR TREATING NOTCH3-ASSOCIATED DISEASES | 2007 |
|
RU2461569C2 |
